Actuate Announces Scientific Reports Publication on Elraglusib's …
网页7 小时之前 · CHICAGO, FORT WORTH - Actuate Therapeutics, Inc. (NASDAQ: ACTU) ('Actuate' or the 'Company'), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3), announced the Scientific Reports publication of novel mechanistic data for its development ...
Actuate Announces Scientific Reports Publication on Elraglusib’s …
网页1 天前 · Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy including EMT, NF-kB-mediated resistance and several DDR pathways. Elraglusib also acts as a mediator of ...
Actuate Announces Scientific Reports Publication on ... - BioSpace
网页1 天前 · Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy including EMT, NF-kB-mediated resistance and several DDR pathways.
Actuate Announces Scientific Reports Publication on Elraglusib
网页1 天前 · --Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of ...
网页You work with e.reports using Actuate Information Console or Actuate Management Console: Actuate Information Console is a tool that report users use to access reports in an Encyclopedia volume. For more information about Actuate Information Console, see Using Information Console. Actuate Management Console is a …
2024-09-23 | Actuate Announces Scientific Reports Publication on ...
网页1 天前 · CHICAGO and FORT WORTH, Texas, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to …
Actuate - OpenText
网页In January 2015, OpenText™ acquired Actuate Corporation, adding powerful analytics to the OpenText product portfolio and enabling companies to analyze and visualize a broad range of structured, semi-structured, and unstructured data.
Working with Actuate e.Report Designer Professional - OpenText
网页A report developer uses Actuate e.Report Designer Professional to design, build, and distribute structured content. The content can be a richly formatted report, a library of reusable report components, or a template for building reports.
Actuate Corporation - Wikipedia
网页Actuate Corporation is a reporting, analytics and customer communications software company based in San Mateo, California, part of the San Francisco Bay Area and Silicon Valley. The company’s software is intended for use in the finance, government, manufacturing, telecommunications, and healthcare industries, among others.
Creating a Report Design in Actuate e.Report Designer Professional - Oracle
网页A report design file defines the layout and behavior for one report. In this exercise, a new report design is created from scratch, using library components.
- 某些结果已被删除